Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency: The Implication of Critical Limb Ischemia and TASC II C/D Disease.

@article{Nishibe2015EndovascularTF,
  title={Endovascular Therapy for Femoropopliteal Artery Disease and Association of Risk Factors With Primary Patency: The Implication of Critical Limb Ischemia and TASC II C/D Disease.},
  author={Toshiya Nishibe and Kiyohito Yamamoto and Yoshimasa Seike and Hitoshi Ogino and Masayasu Nishibe and Jun Koizumi and Alan Dardik},
  journal={Vascular and endovascular surgery},
  year={2015},
  volume={49 8},
  pages={236-41}
}
The treatment of femoropopliteal artery disease remains controversial, without clear guidelines specifying the indications for endovascular therapy (EVT). Accordingly, we retrospectively examined our experience of using EVT to treat femoropopliteal artery disease. A total of 91 limbs in 82 patients underwent EVT for the treatment of femoropopliteal artery… CONTINUE READING